Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Rodman David Malcom sold 22,575 Mineralys Therapeutics, Inc. shares (Form 4)

Traded May 11 to May 13, 2026 · Filed May 13, 2026

From May 11 to May 13, 2026, Rodman David Malcom (Chief Medical Officer) sold 22,575 Mineralys Therapeutics, Inc. shares at an average US$28.91 for US$653K under a trading plan, leaving 63,443 shares. Filed May 13, 2026 (Form 4).

Sold
22,575 shares
Price
US$28.91 average (US$28.58 to US$29.71)
Value
US$653K
Holding after
63,443 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 11, 2026Common StockOption exercise2,171US$16.0071,963Direct
May 11, 2026Common StockSale2,171US$29.7169,792Direct
May 12, 2026Common StockOption exercise6,348US$1.0876,140Direct
May 12, 2026Common StockSale6,348US$29.3669,792Direct
May 13, 2026Common StockOption exercise3,541US$10.2073,333Direct
May 13, 2026Common StockOption exercise4,166US$14.2577,499Direct
May 13, 2026Common StockSale14,056US$28.5863,443Direct

Source

View original at SEC

Related